Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, ...

Company halting further development of imvotamab (CD20 x CD3) and IGM-2644 (CD38 x CD3)– – Company reducing its workforce by 73% –– Cash and ...

CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors Proceeds will be used to support the advancement of multiple first-in-class and ...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

We’ll do an IgE test to figure out what’s causing those reactions.” When my doctor said those words, I nodded like I knew ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

"We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.